This receipt is still in the Pro early-access window — public in 23h.
Upgrade to Pro for 24-48h early access on every new drop + weekly newsletter + category alerts.
Upgrade — $9.99/mo
On April 29, 2026, a federal judge imposed a $5.5 billion criminal sentence on Purdue Pharma, the maker of OxyContin, formalizing the company's guilty plea to deceiving federal drug regulators and paying kickbacks to doctors to boost opioid prescriptions. The conviction is the last step before the company is dissolved and replaced by a new state-controlled entity, Knoa Pharma. No executives or members of the Sackler family who own the company faced criminal charges.
“On April 29, 2026, a federal judge imposed a $5.5 billion criminal sentence on Purdue Pharma, the maker of OxyContin, formalizing the company's guilty plea to deceiving federal drug regulators and paying kickbacks to doctors to boost opioid prescriptions. The conviction is the last step before the company is dissolved and replaced by a new state-controlled entity, Knoa Pharma. No executives or members of the Sackler family who own the company faced criminal charges.”
On April 29, 2026, a federal judge formally sentenced Purdue Pharma to $5.5 billion in criminal fines and penalties, the final legal step in the long collapse of the company that lit the fuse on the American opioid epidemic. The sentence cemented Purdue's guilty plea to federal crimes: deceiving the regulators meant to police it, and paying kickbacks to push more OxyContin onto the market.
The conviction rests on conduct Purdue itself acknowledged. The company admitted to impeding the Drug Enforcement Administration's efforts to fight the addiction crisis, to feeding misleading information to regulators to inflate its manufacturing quotas, and to running a kickback machine: paying doctors through a speakers program to write more prescriptions, and paying an electronic health records vendor to nudge physicians toward prescribing opioids. The danger of aggressive OxyContin marketing was not a blind spot. It was a strategy.
The sentence landed on the corporation, not on people. As the judge acknowledged from the bench, those who started the epidemic will not serve a sentence. No executives were charged, and no members of the Sackler family, who own Purdue, faced criminal liability. Thirty-six victims spoke at the hearing; many objected to a deal that dissolves the company but leaves its architects free.
Get the 5 biggest receipts every week, straight to your inbox — plus an exclusive PDF: The Top 10 Conspiracy Theories Proven True in 2025-2026. No spam. No agenda. Just the papers they couldn't hide.
You just read "Purdue Pharma Gets $5.5B Criminal Sentence for Lying to Regu…". We send ones like this every week.
No one's said anything yet. Be the first to drop your take.
The criminal sentence sits alongside a separate bankruptcy settlement in which the Sacklers agreed to contribute up to $7 billion over 15 years, with roughly $850 million earmarked for individual victims. Purdue is being replaced by Knoa Pharma, a board appointed by the states, meant to redirect proceeds toward addiction treatment and overdose-reversal medicines.
Beat the odds
This had a 0.3% chance of leaking — someone talked anyway.
Conspirators
~300Network
Secret kept
2.4 years
Time to 95% exposure
500+ years